Genor Biopharma targets $371m from Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Genor Biopharma targets $371m from Hong Kong IPO

Jonathan Breen
September 23, 2020 06:45 AM
Pharma_drugs_adobe_575x375.jpg

JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Macquarie GroupJP MorganEquity IPOsHealth and BiotechEquityChina Merchants Bank CoChinaJefferies LLCHong Kong SARAsiaGreater ChinaHaitong SecuritiesNortheast AsiaAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article